Successful European ESCRS 2017 meeting for ELZA
With 10’000 participants, ESCRS has become one of the largest ophthalmological congresses in the world.
Prof. Farhad Hafezi
October 31, 2017
With 10’000 participants, ESCRS has become one of the largest ophthalmological congresses in the world.
ELZA was present at EUCornea 2017 with a debate in Focus Session 5, where Farhad Hafezi from ELZA and Frank Larkin from Moorfields debated the pros and cons of PACK-Cross-Linking
Farhad Hafezi becomes visiting professor at one of China’s largest university eye clinics
SmILE more solid than flap-based refractive laser surgery: this recently published research, spearheaded by Walter Sekundo from Germany, shows for the first time that SmILE indeed is biomechanically more solid than flap-based refractive laser surgery approaches
After 4 years of preparation, the new Research Laboratory for Ocular Cell Biology and Biomechanics opens at the USC Roski Eye Institute.
Algorithm predicts CXL effect: in this scientific article, we published a new algorithm that combines the knowledge we accumulated over the past 12 years
The ELZA founder Farhad Hafezi gives an invited lecture on “Past, Present and Future of Cross-Linking”
We are currently developing the technique of slit lamp cross-linking, one crucial step will be to determine whether riboflavin, once applied onto the cornea, remains at saturation levels during a CXL procedure
“Sitting down with” is an interview series of the journal The Ophthalmologist covering selected personalities in ophthalmology.
ELZA founder Prof. Farhad Hafezi speaks about treating therapy-resistant corneal infections with cross-linking (PACK-CXL).